Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Mar;135(5):1219-26.
doi: 10.1038/sj.bjp.0704577.

Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period

Affiliations

Naloxone prevents cell-mediated immune alterations in adult mice following repeated mild stress in the neonatal period

Alberto Loizzo et al. Br J Pharmacol. 2002 Mar.

Abstract

1. Mild stress plus mild pain (solvent injection) applied daily to neonatal mice induces hormonal, behavioural and metabolic changes perduring in the adult life. 2. We investigated whether daily mild stress to neonatal mice induces also long-term defined changes of immune response, and whether immune changes are prevented through repeated administration of the opioid antagonist naloxone. 3. Mild stress plus solvent injection administered from birth to the 21st postnatal day causes not only behavioural and metabolic changes, but also long-term (up to 110 days of life) splenocytes modifications, consisting in: increased release of the Th-1 type cytokines interleukin-2 (IL-2) (from an average of 346 to 788 pg ml(-1)), interferon-gamma (from 1770 to 3942) and tumour necrosis factor-alpha (from 760 to 1241); decreased release of the Th-2 type cytokines IL-4 (from 49.1 to 28.4) and IL-10 (from 1508 to 877). Moreover, enhanced natural killer-cell activity; enhanced proliferative splenocytes properties in resting conditions and following phytohemoagglutinin and concanavalin-A stimulation are observed. Immunological, behavioural and metabolic changes are prevented by the opioid antagonist (-)naloxone (1 mg kg(-1) per day s.c., administered instead of solvent) but not by the biologically inactive enantiomorph (+)naloxone. 4. In conclusion, endogenous opioid systems sensitive to naloxone are involved in long-lasting enhancement of the Th-1 type cytokines and cell-mediated immunological response caused by repeated mild stress administered postnatally.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of mild repeated post-natal stress on cytokine production by PHA-stimulated murine splenocytes, in the four groups of animals. Values are expressed in per cent of controls. (A) Th1-type cytokines. Mean control values in pg ml−1 are: IL-2: 346 (s.e.mean 31); IFN-γ: 1770 (75); TNF-α: 760 (53); (B) Th2-type cytokines. Mean values (s.e.mean) are: IL-4: 49 (3); IL-10: 1508 (135); IL-1β: 376 (28). Differences of C and NA groups versus W and NA+ are always highly significant, with the exception of IL-1β levels, which showed quite similar values in all groups. Mice underwent treatment up to post-natal-day 21, and analyses at day 110.
Figure 2
Figure 2
Effects induced by mild repeated post-natal stress on natural killer cell activity of splenocytes of CD-1 male mice. Cytotoxic activities are expressed as lytic units LU33 10−7 effector cells. Mice underwent treatment up to day 21 of life, and analyses at day 110.

Similar articles

Cited by

References

    1. AGARWAL S.K., MARSHALL G.D., JR Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J. Interferon Cytokine Res. 2001;21:147–155. - PubMed
    1. AKIL H.A., MORANO M.I.Stres Psychopharmacology. The Fourth Generation of Progress 1995NY: Raven Press; 773–786.Bloom, F.E., Kupfer, D.J. ed
    1. ANAND K.J. Effects of perinatal pain and stress. Progr. Brain Res. 2000;122:117–129. - PubMed
    1. BELKOWSKI S.M., ALICEA C., EISENSTEIN T.K., ADLER M.W., ROGERS T.J. Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50, 488H. J. Pharmacol. Exp. Ther. 1995;273:1491–1496. - PubMed
    1. BUCKETT W.R. Circadian and seasonal rhythm in stimulation-produced analgesia. Experientia. 1981;37:878–879. - PubMed

Publication types

LinkOut - more resources